Take a deeper dive into the differences between germline and somatic mutations and what this means for patients with cancer and their families. Considerations for tumor types where somatic and germline testing comes into play for colorectal, ovarian, pancreatic, and prostate cancers will be discussed.

• Alicia Morgan, MD, MPH, Associate Profession or Medicine (Hematology and Oncology), Robert H. Lurie Comprehensive Cancer Center of Northwestern University
• Leigha Senter-Jamieson, MS, LGC, Associate Director, OSU Genetic Counseling Graduate Program; Associate Professor, Internal Medicine
• Bryson Katona, MD, PhD, Assistant Professor of Medicine, Hospital of the University of Pennsylvania; Director, Gastrointestinal Cancer Genetics; Program Director, Gastrointestinal Cancer Risk Evaluation Program; Member, Abramson Cancer Center

The Foundational elements of biomarker testing and application in cancer care. Webinar topics include biomarker basics, inherited cancers, laboratory medicine, cost and coverage, and tumor-specific case examples.
Register